FOLH1 and adrenocortical carcinoma, hereditary: Because the localization of PSMA in AdCC is mainly cytoplasmic or concentrated at the luminal side of the cell membrane, therapy with Alpha-emitting 225Ac-PSMA-617 might also be a viable therapeutic option [47].